BCBusiness

November 2018 – What's Up, Chip?

With a mission to inform, empower, celebrate and advocate for British Columbia's current and aspiring business leaders, BCBusiness go behind the headlines and bring readers face to face with the key issues and people driving business in B.C.

Issue link: http://digital.canadawide.com/i/1036952

Contents of this Issue

Navigation

Page 22 of 71

tOp: aLBERt LaW; Right: dELOittE nOVEmBER 2018 BCBusiness 23 A strong advocate of cannabis for medi- cal treatment, Caroline MacCallum says her patients brought the idea to her. MacCallum grew up in Newfoundland, where she earned a pharmacy degree and began medical stud- ies. After graduating from internal medicine at UBC in 2013, she worked at several clinics. There she met people with a range of health problems who had turned to cannabis because other treatments didn't work. MacCallum was skeptical of the lack of scienti-c evidence. "But patients were telling me that it was working," she says. Deciding to help people access safe medical cannabis, MacCallum saw how powerful it was: "People who might have come to me with 10 problems, it was helping a lot of the conditions, a lot of the symptoms, and we were able to whittle down their prescription list." Today, she is medical director of the Green- leaf Medical Clinic in Langley, where she has seen some 3,000 patients. Canada's -rst medi- cal cannabis clinic, Greenleaf opened in 2011. It charges patients a fee and uses only Health Canada–approved cannabis to treat illnesses ranging from chronic pain and cancer symp- toms to migraine and addiction. "We weigh the risks and the bene-ts, and we educate, and we monitor for drug interac- tions," says MacCallum, who is also a clinical instructor with UBC's department of medicine, an adjunct professor with the faculty of phar- maceutical sciences and an associate member of the palliative care division. She recently won ethics approval from the university to turn Greenleaf into a patient registry. With consent, she can now explore what cannabis varieties work for particular diseases, she says. Among other research e'orts, MacCallum is working with several groups that aim to launch randomized clinical trials studying cannabis's e'ect on neurological and psychiatric condi- tions such as seizures and traumatic brain injury. This year, she co-authored what she calls the -rst paper of its kind, for the European Jour- nal of Internal Medicine, on medical cannabis administration and dosing. —N.R. T H E p H y s I C I A N CAroline MacCAlluM Medical director, greenleaf Medical Clinic LIKe A WeeD size of the recreational cannabis market, 2019 good MEdicinE besides prescribing cannabis, Caroline macCallum researches its benefits Estimated current size projected legal market size DiFFerenCe $470 - $1,590 miLLiOn DiFFerenCe $150 - $500 miLLiOn C A N A D A W E s T $1. 3 4 - $ 2 .75 Billion $1.81 - $ 4. 3 4 Billion $ 0.4 2 - $ 0.8 7 Billion $ 0.57 - $1. 37 Billion

Articles in this issue

Archives of this issue

view archives of BCBusiness - November 2018 – What's Up, Chip?